Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

被引：0
|
作者：
Michael Kurnellas
Ananya Mitra
Tina Schwabe
Robert Paul
Andrew E. Arrant
Erik D. Roberson
Michael Ward
Felix Yeh
Hua Long
Arnon Rosenthal
机构：
[1] Alector,Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, and Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology
[2] Inc.,undefined
[3] University of Alabama at Birmingham,undefined
[4] Neuron23,undefined
[5] Nine Square Therapeutics,undefined
[6] Inc.,undefined
[7] Genentech,undefined
来源：
Journal of Translational Medicine | / 21卷
关键词：
Frontotemporal dementia; Latozinemab; Neuroprotection; Phase 1 clinical trial; Pharmacodynamics; Pharmacokinetics; Progranulin; Safety; Sortilin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
    Kurnellas, Michael
    Mitra, Ananya
    Schwabe, Tina
    Paul, Robert
    Arrant, Andrew E.
    Roberson, Erik D.
    Ward, Michael
    Yeh, Felix
    Long, Hua
    Rosenthal, Arnon
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [2] Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia
    Ward, Michael
    Carter, Lawrence P.
    Huang, Julie Y.
    Maslyar, Daniel
    Budda, Balasubrahmanyam
    Paul, Robert
    Rosenthal, Arnon
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (01)
  • [3] Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia
    Mukherjee, Odity
    Wang, Jun
    Gitcho, Michael
    Chakraverty, Sumi
    Taylor-Reinwald, Lisa
    Shears, Shantia
    Kauwe, John S. K.
    Norton, Joanne
    Levitch, Denise
    Bigio, Eileen H.
    Hatanpaa, Kinuno J.
    White, Charles L.
    Morris, John C.
    Cairns, Nigel J.
    Goate, Alison
    HUMAN MUTATION, 2008, 29 (04) : 512 - 521
  • [4] Amusia as an early manifestation of frontotemporal dementia caused by a novel progranulin mutation
    Sagrario Barquero
    Estrella Gomez-Tortosa
    Manuel Baron
    Alberto Rabano
    David G. Munoz
    Adriano Jimenez-Escrig
    Journal of Neurology, 2010, 257 : 475 - 477
  • [5] Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia
    Wilke, Carlo
    Gillardon, Frank
    Deuschle, Christian
    Hobert, Markus A.
    Jansen, Iris E.
    Metzger, Florian G.
    Heutink, Peter
    Gasser, Thomas
    Maetzler, Walter
    Blauwendraat, Cornelis
    Synofzik, Matthis
    NEURODEGENERATIVE DISEASES, 2017, 17 (2-3) : 83 - 88
  • [6] Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
    Sun, Li
    Eriksen, Jason L.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 (04) : 632 - 642
  • [7] Core features of frontotemporal dementia recapitulated in progranulin knockout mice
    Ghoshal, N.
    Dearborn, J. T.
    Wozniak, D. F.
    Cairns, N. J.
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 395 - 408
  • [8] FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation
    Deng, Bin
    Zheng, Zhe
    Zheng, Jialing
    Yang, Wanlin
    Huang, Yu
    Luo, Yuqi
    Jin, Dana
    Shen, Lu
    Jin, Kunlin
    Wang, Qing
    AGING AND DISEASE, 2021, 12 (07): : 1741 - 1752
  • [9] Progranulin mutation analysis: Identification of one novel mutation in exon 12 associated with frontotemporal dementia
    Aswathy, Peethambaran Mallika
    Jairani, Pushparajan Sulajamani
    Raghavan, Sheela Kumari
    Verghese, Joe
    Gopala, Srinivas
    Srinivas, Priya
    Mathuranath, Pavagada Sivasankara
    NEUROBIOLOGY OF AGING, 2016, 39 : 218.e1 - 218.e3
  • [10] Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family
    Chiang, Huei-Hsin
    Rosvall, Lina
    Brohede, Jesper
    Axelman, Karin
    Bjork, Behnosh F.
    Nennesmo, Inger
    Robins, Tiina
    Graff, Caroline
    ALZHEIMERS & DEMENTIA, 2008, 4 (06) : 414 - 420
12345